SG Americas Securities
INSY

SG Americas Securities’s Insys Therapeutics, Inc. INSY Stock Holding History

SG Americas Securities’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11,657
Closed -$54K – 3636
2019
Q1 		$54K Buy
+11,657
New +$55.2K ﹤0.01% 3181
2017
Q4 		– Sell
-11,324
Closed -$101K – 3860
2017
Q3 		$101K Buy
11,324
+415
+4% +$4.28K ﹤0.01% 3200
2017
Q2 		$138K Buy
+10,909
New +$129K ﹤0.01% 2696
2016
Q2 		– Sell
-11,435
Closed -$183K – 3175
2016
Q1 		$183K Buy
11,435
+5,301
+86% +$101K ﹤0.01% 2255
2015
Q4 		$176K Sell
6,134
-789
-11% -$21.9K ﹤0.01% 2163
2015
Q3 		$197K Sell
6,923
-12,439
-64% -$458K ﹤0.01% 1476
2015
Q2 		$695K Sell
19,362
-544
-3% -$16.9K ﹤0.01% 1263
2015
Q1 		$579K Sell
19,906
-144
-0.7% -$3.81K ﹤0.01% 1388
2014
Q4 		$423K Buy
20,050
+12,434
+163% +$246K ﹤0.01% 1769
2014
Q3 		$148K Buy
+7,616
New +$120K ﹤0.01% 2163

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

SG Americas Securities's INSY Position: Q2 2019 in Review

SG Americas Securities sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 11,657 shares — an estimated $54K sold.

SG Americas Securities first reported a position in INSY in Q3 2014 and held it in 10 quarters. The position peaked at $695K in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • SG Americas Securities reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • SG Americas Securities sold 11,657 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $54K.
  • SG Americas Securities first reported a position in Insys Therapeutics, Inc. in Q3 2014 and held it in 10 quarters.
  • SG Americas Securities's Insys Therapeutics, Inc. position peaked at $695K in Q2 2015.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on SG Americas Securities's 13F filing for Q2 2019, filed 29 Jul 2019.